Hasil Pencarian (1)
biotech
Lisocabtagene maraleucel is a chimeric antigen receptor (CAR) T-cell therapy, similar to [brexucabtagene autoleucel] and [axicabtagene ciloleucel].[A228493,L31588] Lisocabtagene maraleucel is a genetically modified autologous T-cell therapy that targets CD19,…
Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsAntineoplastic cell and gene therapy
+3
Target Protein:
B-lymphocyte antigen CD19
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik
-